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The effects of piracetam (2 x 200 mg/kg b. w.) injected intraperitoneally for three 
days on erythropoiesis and some functional characteristics of erythrocytes were studied 
in Wistar rats. A significant increase of reticulocytes in relative (by 122,03 %, p < 0,01) 
and in absolute counts (by 109,29 %, p < 0,01), an increase of 59Fе incorporation in 
newly-formed erythrocytes (by 13,80 %) and a significant rise of erythroblasts as 
followed: total counts (by 59,39 %, p < 0,01), proerythroblasts (by 52,87 %, p < 0,05), 
and orthochromatic erythroblasts (by 54,25 %, p< 0,01) were observed in the piracetam-
treated rats. It was accepted that piracetam stimulated erythroid proliferation and 
differentiation. Erythroid deformability enhanced by 14,69 % (p < 0,01) but spontaneous 
haemolysis of erythrocytes reduced by 16,95 % (p < 0,025). Thus it could be suggested 
that piracetam, along with its stimulatory effect on erythropoiesis, improves some of the 
most important functional characteristics of erythrocytes such as deformability and 
oxidative resistance. 
Key-words: Piracetam, erythropoiesis, erythrocyte deformability, spontaneous 
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The positive influence of 
piracetam on learning and memory 
and its antihypoxic effects in nervous 
system are well-known (11,12). 
Recently, its effects outside the 
nervous system were reported as an 
increase of bilirubin and cholesterol 
in bile and uric acid in plasma (5). 
Erythrocyte filterability "in vitro" in 
patients with epilepsy ameliorated 
Address for correspondence: 
T. Ganchev, Dept. of Physiology, Medical 
University, 55 Marin Drinov St, BG-9002 
Varna, BULGARIA 
after piracetam treatment was also 
described (4). 
Having in mind the influence of 
piracetam on metabolic processes in 
the nervous system sue as an 
increased synthesis and utilization of 
A T P , phospholipids and elevated 
extraction ratio of oxygen and glucose 
(13) as well as the above mentioned 
positive effect on erythrocyte 
filterability, we are inclined to suggest 
that piracetam influences positively 
not only on erythrocyte functions, but 
on erythropoiesis rates as well. 
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study were stained by Pappenheim's 
method. Index of erythroblast 
maturation was calculated. Erythro­
cyte deformability was assessed 
according to Tannert and L u x method 
(1981) in our modification (2) and 
spontaneous haemolysis of 
erythrocytes - by Jager's method 
(1968). Differences between groups 
were tested using Student-Fisher r-test 
and considered significant when the 
p-value was less than 0,05. 
RESULTS AND DISCUSSION 
Data are presented on Table 1 
and Figures 1 through 3. No 
considerable changes were observed 
in erythrocyte counts, haemoglobin 
and haematocrit so the results were 
not mentioned. 
Table 1 
Changes in reticulocyte counts and ^Fe incorporation in newly-formed erythrocytes after 
3 -day piracetam treatment (2 x 200 mg/kg b. w.) in rats 
Parameters N Experiment N Control % 
Reticulocytes - "per mille" 40 66,85 ± 10,78 37 30,10 ±4,35 + 122,03 
(P<0,01) 
Reticulocytes 10^/1 35 431,42 ±62,90 32 206,13 ±31,93 + 109,29 
(P<0,01) 
Incorporation of ^ F e j n 
newly-formed erythrocytes -
% 
33 27,52 ± 1,25 34 24,18 ± 1,69 + 13,80 
(Р > 0,05) 
Data are presented as means ± SEM. Percent deviation calculated against the controls. 
+ increase, N - number of animals per group 
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Aim of our study was to 
examine the influence of piracetam in 
"in vivo" experiments on 
erythropoiesis and some functional 
characteristics of mature erythrocytes, 
as far as these problems remained 
understudied. 
M A T E R I A L AND METHODS 
The experiment was carried out 
on 136 Wistar rats weighing 170-180 
g. The experimental group (n=70) was 
treated with piracetam (Pyramem -
"Pharm.") in a dose of 200 mg/kg b. 
w. twice daily, intraperitoneally, for 3 
days. The controls (n=66) were 
injected with saline. The parameters 
of erythropoiesis, including 5 9 F e 
incorporation in newly-formed 
erythrocytes were determined by 
methods described elsewhere (2). 
Bone marrow smears for a cytologic 
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Fig. 1. Changes in erythrocyte deformability 
after 3-day piracetam treatment (200 mg/kg b. 
w. twice daily) in rats. Data are presented as 
percent deviation from the controls which are 












p < 0,02 
PIRACETAM CONTROL 
Fig. 2. Spontaneous haemolysis of 
erythrocytes after 3- day piracetam treatment 
(2x200 mg/kg b. w.) 
- piracetam treated (n-15) 
- saline treated (n= 15), controls 
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Fig. 3. Erythroblast shifts influenced by 
piracetam. 
Data are presented as percent deviation 
from the controls. (+) - increase, (-) -
decrease 
EB - erythroblasts, PREB - proerythro­
blasts, BAEB - basophil erythroblasts, 
POCB - polychromatic erythroblasts, OEB -
orthochromatic erythroblasts 
From Table l it can be seen that 
piracetam treatment significantly 
increases the reticulocyte counts - in 
relative (by 122,03 %; p < 0,01) and 
absolute (by 109,29 %; p < ,0,01) 
values as compared to the controls. 
5 9 F e incorporation in newly-formed 
erythrocytes also shows a tendency to 
increase by 13,80 % (p < 0,05). The 
data we have obtained point to the 
suggestion that piracetam treatment 
stimulates erythroid regeneration and 
haemoglobin formation. The 
established significant increase of the 
total number erythroblasts in bone 
marrow by 59,39 % (p < 0,01) (Fig. 3) 
supports this suggestion as well. The 
increase of P R E B in bone marrow by 
52,87 % (p < 0,025) may be 
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considered as a manifestation of 
enhanced transition of unrecognizable 
erythroid precursors to the 
erythroblast section of this cell line 
under the influence of piracetam. The 
tendency towards lower values of 
РОЕВ and B A E B along with the 
significant increase of O E B by 54,25 
% (p < 0,01) could be interpreted as a 
result of the direct stimulatory effect 
exerted by piracetam on proliferation 
and, predominantly, on differentiation 
and maturation of erythroblasts. The 
raised index of maturation of 
erythroblasts by 10,18 % (p < 0,01) 
observed in the experimental group 
reflecting the increased number of 
mature erythroblasts supports this 
suggestion, too. It is possible that the 
direct positive metabolic influence of 
piracetam (well-known for other cell 
systems (13) on erythroid bone 
marrow cells, to account for this 
stimulation of erythropoiesis. The 
positive influence of piracetam on 
adrenergic neurotransmission should 
not be excluded as well (14). 
Undoubted evidence exists that the 
activated adrenergic system has 
stimulatory effects on erythropoiesis 
(8). 
Additional information about 
the properties of mature erythrocytes 
influenced by piracetam under normal 
conditions could be obtained from 
determination of some functional 
characteristics of mature erythro­
blasts. In vitro studies show that low 
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doses of piracetam treatment (12 
mg/kg) in patients with epilepsy 
improve the aggravated erythrocyte 
filterability (4). In our "in vivo" 
experiment with higher doses of 
piracetam, erythrocyte deformability 
significantly increases by 14,69 % (p 
< 0,01) (Fig. 1). The stimulation of 
metabolic processes in erythroid cells 
(3,7) and the raise of reticulocyte 
counts in blood (6) could explain that 
increase. The fact that piracetam 
reduces phosphorylation of membrane 
proteins should be also considered 
(11). Obviously, the raised 
reticulocyte counts under piracetam 
influence and the stimulated 
metabolic processes in erythroid cells 
determine a better deformability. As a 
result erythrocytes show improved 
functional properties for transition 
trough critical places of 
microcirculation and delivery of 
oxygen to the tissues. Erythrocyte 
spontaneous haemolysis after 
piracetam treatment was decreased by 
16,95 % (p < 0,025) (Fig. 2). A 
possible explanation may be that 
piracetam ameliorates metabolic 
processes in erythroid cells and the 
stability of erythrocyte membranes. 
Hence, the erythrocyte becomes more 
resistant to the influence of 
haemolytic factors. In this respect, the 
increase of reticulocytes which are 
known to be more resistant to 
haemolytic influences should be 
considered as well. Data exist about a 
Influence of piracetam on erythropoiesis in rats 
direct suppression of lipid 
peroxidation in rat brain tissue by 
piracetam (1) which also must be 
taken into account. It may be 
suggested that erythrocyte resistance 
against lipid peroxidation products is 
increased as well. 
most important functional 
characteristics of erythrocytes such as 
deformability and oxidative 
resistance. It is supposed that 
piracetam may be used as a 
therapeutic means in cases with 
haemorheologic disturbances accom­
panied by increased erythrocyte 
rigidity and formation of oxygen 
radicals. 
In conclusion, our data show 
that piracetam not only stimulates 
erythropoiesis, but also improves the 
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Влияние на пирацетам върху еритропоезата у плъхове 
Т. Ганчев, Е. Дянков*, Е. Станчева, П. Николова, Р. Захариева, М. 
Великова 
Резюме: Влиянието на пирацетам (2 х 200 mg/kg телесна маса, i. р. за 3 дни) върху 
еритропоезата и някои функционални характеристики на еритроцитите е проучено 
Катедра по физиология и *Катедра по педиатрия, 
Медицински университет - Варна, Варна 
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при бели плъхове от порода Wistar. У третираните с пирацетам плъхове се 
наблюдава значимо повишение на ретикулоцитите "про мили" със 122,03 % (р < 
0,01), в абсолютни стойности - със 109,29 % (р < 0,01), на включеното ^ 9 р е в 
новообразуваните еритроцити - с 13,80 %, както и значимо увеличение на 
еритробластите: общия им брой - с 59,39 % (р < 0,01), проеритробластите - с 52,87 
% (р < 0,05) и оксифилните еритробласти - с 54,25 % (р < 0,01). Приема се, че 
пирацетамът стимулира еритроидната пролиферация и диференциация. 
Еритроцитната деформабилност показва увеличение с 14,69 %, а спонтанната 
хемолиза на еритроцитите - по-ниски стойности с 16,95 % (р < 0,025). 
Следователно пирацетамът не само стимулира еритропоезата, но и подобрява едни 
от най-важните функционални свойства на еритроцита - неговата деформабилност 
и прекисна устойчивост. 
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